国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
10期
1216-1220
,共5页
赖绍斌%梁维基%伍锦旋%邓碧池%赵崇毅%梁雅
賴紹斌%樑維基%伍錦鏇%鄧碧池%趙崇毅%樑雅
뢰소빈%량유기%오금선%산벽지%조숭의%량아
氯吡格雷抵抗%复方丹参滴丸%血小板聚集率
氯吡格雷牴抗%複方丹參滴汍%血小闆聚集率
록필격뢰저항%복방단삼적환%혈소판취집솔
Clopidogrel resistance%Compound danshen drop pill%Platelet aggregation
目的 探讨复方丹参滴丸对氯比格雷抵抗患者的干预效果.方法 采用比浊法测定血小板聚集率,将氯比格雷抵抗患者58例随机分为两组,氯比格雷+复方丹参滴丸组及单服氯吡格雷组,每组29例.干预2周后分别复查血小板聚集率.结果 干预后氯吡格雷+复方丹参滴丸组二磷酸腺甘(ADP)诱导的血小板聚集率为28.25%,较干预前的37.78%下降9.53%(P<0.01);而单用氯吡格雷组十预前后无明显变化(P>0.05).结论 复方丹参滴丸可以增强患者对氯比格雷的敏感性,减轻氯比格雷抵抗,两药有协同抗血小板作用.
目的 探討複方丹參滴汍對氯比格雷牴抗患者的榦預效果.方法 採用比濁法測定血小闆聚集率,將氯比格雷牴抗患者58例隨機分為兩組,氯比格雷+複方丹參滴汍組及單服氯吡格雷組,每組29例.榦預2週後分彆複查血小闆聚集率.結果 榦預後氯吡格雷+複方丹參滴汍組二燐痠腺甘(ADP)誘導的血小闆聚集率為28.25%,較榦預前的37.78%下降9.53%(P<0.01);而單用氯吡格雷組十預前後無明顯變化(P>0.05).結論 複方丹參滴汍可以增彊患者對氯比格雷的敏感性,減輕氯比格雷牴抗,兩藥有協同抗血小闆作用.
목적 탐토복방단삼적환대록비격뢰저항환자적간예효과.방법 채용비탁법측정혈소판취집솔,장록비격뢰저항환자58례수궤분위량조,록비격뢰+복방단삼적환조급단복록필격뢰조,매조29례.간예2주후분별복사혈소판취집솔.결과 간예후록필격뢰+복방단삼적환조이린산선감(ADP)유도적혈소판취집솔위28.25%,교간예전적37.78%하강9.53%(P<0.01);이단용록필격뢰조십예전후무명현변화(P>0.05).결론 복방단삼적환가이증강환자대록비격뢰적민감성,감경록비격뢰저항,량약유협동항혈소판작용.
Objectives To investigate the effects of compound danshen drop pill on clopidogrel resistance. Methods Fifty eight patients with clopidogrel resistance were selected according to platelet aggregation from 232 inpatients who had taken clopidogrel75mg for 24 hours.They were randomized to two groups: compound danshen drop pill plus clopidogrel,clopidogrel only. Platelet aggregation was evaluated later two weeks after interference(P> 0.05 ). Results Adenosine diphosphate(ADP) induced platelet aggregation of the grop compound danshen drop pill plus clopidogrel decreased 9.53%(P<0.01 ),while there was no significant change in clopidogrel only group. Conclusion Compound danshen drop pill improve platelet sensitivity to clopidogrel,and has synergistic anti-platelet effects,thus could be administered to interfere clopidogrel resistance effectively.